Noir Nation, a major shift in federal drug policy may be on the way as Trump is expected to sign an executive order easing restrictions on marijuana!

📜 What the Reclassification Means

Currently, marijuana is classified as a Schedule I substance, a category reserved for drugs deemed to have no accepted medical use. The executive order would move cannabis to Schedule III, placing it alongside substances recognized for medical use but still regulated at the federal level.

While this action would not legalize marijuana nationwide, it would reduce federal barriers and signal a major policy shift in how the government approaches cannabis regulation; including for research and medical usage reports CNN.

“We are considering that because a lot of people want to see it — the reclassification, because it leads to tremendous amounts of research that can’t be done unless you reclassify. So, we are looking at that very strongly,” said Trump to reporters in the Oval Office.

🔬 Impact on Research and Industry

Rescheduling marijuana could unlock expanded opportunities for medical and scientific research, an area that has long been restricted due to its Schedule I status. Researchers and institutions may gain greater access to study cannabis for therapeutic benefits and long-term effects.

For the cannabis industry, the move could bring relief from strict federal tax rules, improved access to financial services, and increased legitimacy for businesses operating legally at the state level.

⚖️ Chang In Attitudes

The expected executive order comes as public opinion around marijuana continues to evolve, with a majority of states allowing medical or recreational use in some form. Advocates say the move reflects a growing recognition that outdated federal classifications no longer align with modern science or public sentiment.

🌍 What Comes Next

Noir Nation, while the executive order would be a significant step, implementation would still require federal agencies to finalize changes, and state laws would remain in control of local enforcement and access.

Still, this move could represent a turning point — shifting the national conversation from prohibition toward regulation, research, and reform.